Zuellig buys Symbion Pharmacy business in Australia

The HK-based business group shells out $438 million to add the Symbion Pharmacy business in Australia, owned by Primary Health Care, to its own stable of pharmaceuticals companies.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES